These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3862138)

  • 1. Hypotensive mechanism of acetyl glyceryl ether phosphorylcholine (AGEPC) in dogs. Effects on hemodynamics and humoral factors.
    Otsuka A; Masugi F; Ogihara T; Saeki S; Nagano M; Koyama Y; Tabuchi Y; Kumahara Y
    Prostaglandins Leukot Med; 1985 Jul; 19(1):25-35. PubMed ID: 3862138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs.
    Kenzora JL; Pérez JE; Bergmann SR; Lange LG
    J Clin Invest; 1984 Oct; 74(4):1193-203. PubMed ID: 6480824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
    Sybertz EJ; Watkins RW; Baum T; Pula K; Rivelli M
    J Pharmacol Exp Ther; 1985 Jan; 232(1):156-62. PubMed ID: 3917504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon.
    McManus LM; Pinckard RN; Fitzpatrick FA; O'Rourke RA; Crawford MH; Hanahan DJ
    Lab Invest; 1981 Oct; 45(4):303-7. PubMed ID: 7300244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGEPC, a vasodilator phospholipid with profound circulatory actions.
    Sybertz EJ; Watkins RW; Vemulapalli S; Baum T; Chiu PJ; Barnett A
    Prog Clin Biol Res; 1986; 219():133-56. PubMed ID: 3538024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putative mechanism of hypotensive action of platelet-activating factor in dogs.
    Yamanaka S; Miura K; Yukimura T; Okumura M; Yamamoto K
    Circ Res; 1992 May; 70(5):893-901. PubMed ID: 1568300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of NG-nitro-L-arginine administration on the hemodynamics and plasma hormone levels during endotoxin shock in dogs].
    Takekoshi K; Kasai K; Nakamura T
    Nihon Naibunpi Gakkai Zasshi; 1993 Mar; 69(3):135-48. PubMed ID: 8385633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of acetyl glyceryl ether phosphorylcholine in blood pressure regulation in rats.
    Masugi F; Ogihara T; Saeki S; Otsuka A; Kumahara Y
    Hypertension; 1985; 7(5):742-6. PubMed ID: 4030044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane B2 (TxB2) release following acetyl glyceryl ether phosphorylcholine (AGEPC) infusion in the rabbit.
    McManus LM; Fitzpatrick FA; Hanahan DJ; Pinckard RN
    Immunopharmacology; 1983 Feb; 5(3):197-207. PubMed ID: 6832960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of rabbit platelet phospholipase and thromboxane synthesis by 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor).
    Shaw JO; Klusick SJ; Hanahan DJ
    Biochim Biophys Acta; 1981 Jan; 663(1):222-9. PubMed ID: 7213765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.
    Liang C; Doherty JU; Faillace R; Maekawa K; Arnold S; Gavras H; Hood WB
    J Clin Invest; 1982 Jun; 69(6):1321-36. PubMed ID: 6123523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC).
    Valone FH; Goetzl EJ
    Am J Pathol; 1983 Oct; 113(1):85-9. PubMed ID: 6624880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of platelets in the physiologic alterations of the AGEPC response and of IgE anaphylaxis in the rabbit. Effects of PGI2 inhibition of platelet function.
    Halonen M; Lohman IC; Dunn AM; McManus LM; Palmer JD
    Am Rev Respir Dis; 1985 Jan; 131(1):11-7. PubMed ID: 3881060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of 1-O-hexadecyl- and 1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine-stimulated granule enzyme release from human neutrophils.
    Smith RJ; Bowman BJ; Iden SS
    Clin Immunol Immunopathol; 1983 Jul; 28(1):13-28. PubMed ID: 6872358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of platelet-activating factor on coronary circulation of the domestic pig.
    Feuerstein G; Boyd LM; Ezra D; Goldstein RE
    Am J Physiol; 1984 Mar; 246(3 Pt 2):H466-71. PubMed ID: 6703081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
    Miller OV; Ayer DE; Gorman RR
    Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig.
    Levi R; Burke JA; Guo ZG; Hattori Y; Hoppens CM; McManus LM; Hanahan DJ; Pinckard RN
    Circ Res; 1984 Feb; 54(2):117-24. PubMed ID: 6692502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of digoxin as inhibitor of the in vivo effects of acetyl glyceryl ether phosphorylcholine (AGEPC) in mice.
    Kelefiotis D; Lanara E; Vakirtzi-Lemonias C; Siafaka A; Mavris M; Lazanas M; Demopoulos CA
    Life Sci; 1988; 42(6):623-33. PubMed ID: 3339951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension.
    Ando K; Noda H; Ogata E; Fujita T
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):7-10. PubMed ID: 1383633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.
    Heffner JE; Shoemaker SA; Canham EM; Patel M; McMurtry IF; Morris HG; Repine JE
    J Clin Invest; 1983 Feb; 71(2):351-7. PubMed ID: 6822668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.